Drug Testing Locations - Haverhill, MA

Drug Testing in Haverhill, MA

Haverhill, Massachusetts Statistics

In 2022, opioid-related overdose deaths in Haverhill, MA, Essex County, increased by 15% compared to the previous year.

Haverhill, MA, in Essex County, reported 175 emergency room visits due to substance abuse in 2022, according to state health records.

The city of Haverhill, Essex County, recorded a 30% increase in drug-related crimes based on the latest police reports for 2022.

A survey conducted in Haverhill, MA, in 2022 revealed that 26% of high school students admitted to using illicit drugs.

In Essex County, Haverhill had the third-highest number of opioid prescriptions per capita in 2022.

Reports from Haverhill's public health department in 2022 indicate a 22% rise in Naloxone (Narcan) administrations by emergency services.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Haverhill, MA & Drug Testing Policies

Employers in Haverhill, MA, have implemented drug testing policies to manage workplace safety and productivity. Many adhere to guidelines set forth by the U.S. Department of Labor ensuring fair and transparent testing processes.

In addition to compliance with federal guidelines, businesses collaborate with local health services, offering support programs for employees struggling with substance use. These initiatives have proven effective in reducing absenteeism and increasing workplace safety across Essex County.

For specific industry guidelines, the Massachusetts Office of Labor and Workforce Development provides resources and compliance assistance. Learn more on their website.

Government Efforts with Drug Problems in Haverhill, MA

The government of Haverhill, MA, in Essex County, has been actively working to address the city's drug problems. Initiatives such as the Haverhill Drug Free Alliance aim to provide education and resources to the community. More information can be found on the Massachusetts Department of Public Health website.

Efforts include collaborations between local law enforcement and community organizations to enhance outreach programs that target both prevention and recovery. The Essex County Sherriff's Department is key in these efforts, offering resources and programs to reduce recidivism among offenders. Visit their website here.

Local Drug Busts & News in Haverhill, MA

Haverhill, MA, in Essex County, has been the scene of numerous drug busts, reflecting ongoing enforcement efforts by local police. In April 2023, a major operation led to the seizure of significant quantities of illicit drugs, highlighting the city's proactive approach to tackling drug trafficking.

Public awareness events, often organized by community coalitions and health departments, aim to inform residents about the dangers of substance abuse and available resources for recovery. Events like annual health fairs also feature presentations by law enforcement and healthcare officials.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Haverhill, MA. Trusted by employers nationwide for accurate results and exceptional service.

Massachusetts DOT/Non DOT Physicals

Massachusetts Vision Tests

Massachusetts Audiograms

Massachusetts Respirator Fit Tests

Massachusetts Lift Tests

Massachusetts Background Checks

Clinical Testing Services

TB Testing in MA

Diabetes Testing in MA

Infectious Disease Testing in MA

Sickle Cell Anemia Testing in MA

Women/Men's Health Testing in MA

Resources & Citations

Massachusetts Executive Office of Health and Human Services

Lawrence General Hospital, Haverhill Location

American Society of Addiction Medicine

Agency for Healthcare Research and Quality

National Institute on Drug Abuse

Harvard Health

McLean Hospital

Boston Recovery Services

National Institute on Alcohol Abuse and Alcoholism

Substance Abuse and Mental Health Services Administration

Drug Testing Near Haverhill, MA

Boxford, MA

North Andover, MA

Andover, MA

Shawsheen Village, MA

Amesbury Town, MA

Methuen, MA

Lawrence, MA

Georgetown, MA

West Newbury, MA

Merrimac, MA

West Boxford, MA

Groveland, MA

Essex, MA

Frequently Asked Questions

Customer Reviews